Related references
Note: Only part of the references are listed.Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Skin and platelet α-synuclein as peripheral biomarkers of Parkinson's disease
AW Michell et al.
NEUROSCIENCE LETTERS (2005)
Early-onset dementia with Lewy bodies
M Takao et al.
BRAIN PATHOLOGY (2004)
Increased β-secretase activity in cerebrospinal fluid of Alzheimer's disease subjects
RMD Holsinger et al.
ANNALS OF NEUROLOGY (2004)
Cerebrospinal fluid tau and β-amyloid -: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
CM Clark et al.
ARCHIVES OF NEUROLOGY (2003)
TorsinA and heat shock proteins act as molecular chaperones:: suppression of α-synuclein aggregation
PJ McLean et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia
K Nagga et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2002)
Staging of cytoskeletal and β-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease
EB Mukaetova-Ladinska et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
α-synuclein inclusions in Alzheimer and Lewy body diseases
EB Mukaetova-Ladinska et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies
M Higuchi et al.
EXPERIMENTAL NEUROLOGY (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)